Tekla Capital Management LLC Successfully Launches Tekla World Healthcare Fund

Boston, MA – June 30, 2015 – Tekla Capital Management LLC is pleased to announce the successful initial public offering of Tekla World Healthcare Fund (the “Trust”), a closed-end management investment company managed by Tekla Capital Management LLC (“Tekla”). 

The Trust priced an offering of 29 million shares at a price of $20.00 per share, for a total issuance of $580 million. The total issuance may reach up to $667 million should the underwriters exercise their over-allotment option in full, which may or may not occur. Shares commenced trading on the New York Stock Exchange on June 26, 2015 under the ticker symbol THW. Investors are able to view the Trust’s net asset value by using the ticker symbol XTHWX.

With this offering, Tekla endeavors to build upon the success of its three existing healthcare-focused closed-end funds - Tekla Healthcare Investors, Tekla Life Sciences Investors and Tekla Healthcare Opportunities Fund.

The Trusts’s investment objective is to seek current income and long-term capital appreciation. Under normal market conditions, the Trust expects to invest at least 80% of its managed assets in U.S. and non-U.S. companies engaged in the healthcare industry including equity securities and debt securities.  The Trust expects to invest at least 40% in companies organized or located outside the United States. THW’s portfolio will be dynamically allocated among investments in the various subsectors that comprise the healthcare sector.

The lead managing underwriters of the offering were Wells Fargo Securities, LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated, Morgan Stanley & Co. LLC, UBS Securities LLC and Ameriprise Financial Services, Inc.

Tekla, the Trust’s investment adviser, is a Boston, MA based healthcare-focused investment manager with approximately $2.7 billion of assets under management as of March 31, 2015. Tekla also serves as investment adviser to Tekla Healthcare Investors (NYSE: HQH), Tekla Life Sciences Investors (NYSE: HQL) and Tekla Healthcare Opportunities Fund (NYSE: THQ), closed-end funds that invest in companies in the healthcare industries. Information regarding the aforementioned funds and Tekla can be found at www.teklacap.com.

Shares of closed-end investment companies usually trade on a national stock exchange, and these shares frequently trade at a discount to their net asset value, which may increase investors’ risk of loss.

Tekla World Healthcare Fund is a newly organized, non-diversified, closed-end management investment company with no operating history. Investors should consider the investment objective and policies, risk considerations, charges and expenses of the Trust carefully before investing. For a prospectus which contains this and other information relevant to an investment in the Trust please contact your securities representative. Investors should read the prospectus carefully before they invest. There can be no assurance that the Trust will be able to achieve its investment objective or structure its investment portfolio as anticipated. This document is not an offer to sell securities and is not soliciting an offer to buy securities in any jurisdiction where the offer or sale is not permitted.

Destra Capital Investments is the Trust’s marketing and investor support services agent. Please contact Destra Capital Investments at THW@destracapital.com or call (877) 855-3434 if you have any questions regarding the Trust.